RxDoctor Payments DataLook up a doctor →

Lenita Hanson

Endocrinology, Diabetes & Metabolism · Port Charlotte, FLNPI 1225128572

Payments from drug & device makers

$1,240,545in general payments, 2019–2025

Across 1,275 payments — averaging $972.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk AS$356K
  • Eli Lilly$234K
  • Boehringer Ingelheim International GmbH$179K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$140K
  • Bayer$112K
  • Sanofi US Services Inc.$74K
  • plus $147K from 45 others
$62,895in research payments, 2019–2025

Across 28 payments — averaging $2246.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bayer$37K
  • Eli Lilly$23K
  • Novo Nordisk AS$4K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,240,545 in reported general payments places this provider in the 95th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.

See all endocrinology, diabetes & metabolism providers in Florida

Other endocrinology, diabetes & metabolism in Port Charlotte

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →